You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
azure platform
About this tag
Discussions on the Azure platform at WindowsForum.com cover its role in AI-native biotech, enterprise R&D with agentic AI, and custom silicon like the Maia 200 inference accelerator. Topics include Microsoft's push for cloud-scale compute, secure model deployment, and reproducible workflows in life sciences, as well as the expansion of Microsoft Discovery for hypothesis generation and simulation. The Maia 200, a 3nm AI accelerator with HBM3e memory, is highlighted for lowering per-token costs in Azure production services. These threads reflect Azure's evolution as a foundation for governed, repeatable evidence in research and cost-efficient AI inference.
Microsoft is pitching Azure and Microsoft for Startups as the foundation for an AI-native biotech operating model in 2026, arguing that young life-sciences companies need cloud-scale compute, secure model deployment, reproducible workflows, and agentic research tooling before they can credibly...
Microsoft is pushing Microsoft Discovery from a tightly controlled private preview into a broader enterprise preview, and that shift matters because it signals more than another Azure SKU entering the market. It marks one of Microsoft’s most ambitious attempts yet to apply agentic AI to the...
Microsoft’s Maia 200 is not a subtle step — it’s a direct, public escalation in the hyperscaler silicon arms race: an inference‑first AI accelerator Microsoft says is built on TSMC’s 3 nm process, packed with massive on‑package HBM3e memory, and deployed in Azure with the explicit aim of...